M&R QP Pharma Consultancy Ltd 11743579 false 2025-01-01 2025-12-31 2025-12-31 The principal activity of the company is Professional, scientific and technical activities Digita Accounts Production Advanced 6.30.9574.0 true 11743579 2025-01-01 2025-12-31 11743579 2025-12-31 11743579 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 11743579 bus:Micro-entities 2025-01-01 2025-12-31 11743579 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 11743579 bus:FilletedAccounts 2025-01-01 2025-12-31 11743579 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 11743579 bus:RegisteredOffice 2025-01-01 2025-12-31 11743579 bus:Director1 2025-01-01 2025-12-31 11743579 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 11743579 countries:UnitedKingdom 2025-01-01 2025-12-31 11743579 2024-01-01 2024-12-31 11743579 2024-12-31 11743579 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 iso4217:GBP xbrli:pure

Registration number: 11743579

M&R QP Pharma Consultancy Ltd
Unaudited Filleted Financial Statements
for the Year Ended 31 December 2025

M&R QP Pharma Consultancy Ltd

Contents

Company Information | 1
Balance Sheet | 2 to 3
Notes to the Unaudited Financial Statements | 2

M&R QP Pharma Consultancy Ltd

Company Information

Director | Dr Mythili Ravindren

Registered office | 49 Stapleton Road Formby Merceyside L37 2YT

Accountants | RS Business Consulting Ltd 11 Approach Road Raynes Park London SW20 8BA

M&R QP Pharma Consultancy Ltd

(Registration number: 11743579)
Balance Sheet as at 31 December 2025

| 2025 £ | 2024 £
Fixed assets | 240 | 240
Current assets | 42,431 | 28,230
Creditors: Amounts falling due within one year | (13,009) | (7,379)
Net current assets | 29,422 | 20,851
Total assets less current liabilities | 29,662 | 21,091
Accruals and deferred income | (25,000) | -
| 4,662 | 21,091
Capital and reserves | 4,662 | 21,091

1 | General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
49 Stapleton Road
Formby
Merceyside
L37 2YT
United Kingdom

These financial statements were authorised for issue by the director on 15 April 2026.

Basis of preparation

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

2 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 2 (2024 - 0).

For the financial year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

M&R QP Pharma Consultancy Ltd

(Registration number: 11743579)
Balance Sheet as at 31 December 2025

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 15 April 2026

......................................... Dr Mythili Ravindren Director